330 related articles for article (PubMed ID: 20685574)
1. Endothelial progenitor cells in pulmonary arterial hypertension.
Diller GP; Thum T; Wilkins MR; Wharton J
Trends Cardiovasc Med; 2010 Jan; 20(1):22-9. PubMed ID: 20685574
[TBL] [Abstract][Full Text] [Related]
2. Endothelial progenitor cells and pulmonary arterial hypertension.
Chen H; Strappe P; Chen S; Wang LX
Heart Lung Circ; 2014 Jul; 23(7):595-601. PubMed ID: 24680485
[TBL] [Abstract][Full Text] [Related]
3. Rescue of monocrotaline-induced pulmonary arterial hypertension using bone marrow-derived endothelial-like progenitor cells: efficacy of combined cell and eNOS gene therapy in established disease.
Zhao YD; Courtman DW; Deng Y; Kugathasan L; Zhang Q; Stewart DJ
Circ Res; 2005 Mar; 96(4):442-50. PubMed ID: 15692087
[TBL] [Abstract][Full Text] [Related]
4. Effect of prepro-calcitonin gene-related peptide-expressing endothelial progenitor cells on pulmonary hypertension.
Zhao Q; Liu Z; Wang Z; Yang C; Liu J; Lu J
Ann Thorac Surg; 2007 Aug; 84(2):544-52. PubMed ID: 17643632
[TBL] [Abstract][Full Text] [Related]
5. Cellular and molecular pathobiology of pulmonary arterial hypertension.
Humbert M; Morrell NW; Archer SL; Stenmark KR; MacLean MR; Lang IM; Christman BW; Weir EK; Eickelberg O; Voelkel NF; Rabinovitch M
J Am Coll Cardiol; 2004 Jun; 43(12 Suppl S):13S-24S. PubMed ID: 15194174
[TBL] [Abstract][Full Text] [Related]
6. Circulating endothelial cells: a new candidate biomarker of irreversible pulmonary hypertension secondary to congenital heart disease.
Smadja DM; Gaussem P; Mauge L; Israël-Biet D; Dignat-George F; Peyrard S; Agnoletti G; Vouhé PR; Bonnet D; Lévy M
Circulation; 2009 Jan; 119(3):374-81. PubMed ID: 19139384
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of vascular endothelial growth factor receptor under hypoxia causes severe, human-like pulmonary arterial hypertension in mice: potential roles of interleukin-6 and endothelin.
Van Hung T; Emoto N; Vignon-Zellweger N; Nakayama K; Yagi K; Suzuki Y; Hirata K
Life Sci; 2014 Nov; 118(2):313-28. PubMed ID: 24412382
[TBL] [Abstract][Full Text] [Related]
8. Autologous transplantation of endothelial progenitor cells attenuates acute lung injury in rabbits.
Lam CF; Liu YC; Hsu JK; Yeh PA; Su TY; Huang CC; Lin MW; Wu PC; Chang PJ; Tsai YC
Anesthesiology; 2008 Mar; 108(3):392-401. PubMed ID: 18292677
[TBL] [Abstract][Full Text] [Related]
9. Endothelial progenitor cells may inhibit apoptosis of pulmonary microvascular endothelial cells: new insights into cell therapy for pulmonary arterial hypertension.
Xia L; Fu GS; Yang JX; Zhang FR; Wang XX
Cytotherapy; 2009; 11(4):492-502. PubMed ID: 19526390
[TBL] [Abstract][Full Text] [Related]
10. Autologous transplantation of bone marrow-derived endothelial progenitor cells attenuates monocrotaline-induced pulmonary arterial hypertension in rats.
Yip HK; Chang LT; Sun CK; Sheu JJ; Chiang CH; Youssef AA; Lee FY; Wu CJ; Fu M
Crit Care Med; 2008 Mar; 36(3):873-80. PubMed ID: 18431275
[TBL] [Abstract][Full Text] [Related]
11. Healing and remodeling of bioengineered pulmonary artery patches implanted in sheep.
Mendelson K; Aikawa E; Mettler BA; Sales V; Martin D; Mayer JE; Schoen FJ
Cardiovasc Pathol; 2007; 16(5):277-82. PubMed ID: 17868878
[TBL] [Abstract][Full Text] [Related]
12. Combined hypoxia inducible factor-1α and homogeneous endothelial progenitor cell therapy attenuates shunt flow-induced pulmonary arterial hypertension in rabbits.
Cao G; Liu C; Wan Z; Liu K; Sun H; Sun X; Tang M; Bing W; Wu S; Pang X; Zhang X
J Thorac Cardiovasc Surg; 2015 Sep; 150(3):621-32. PubMed ID: 26071969
[TBL] [Abstract][Full Text] [Related]
13. Role of apoptosis in pulmonary hypertension: from experimental models to clinical trials.
Jurasz P; Courtman D; Babaie S; Stewart DJ
Pharmacol Ther; 2010 Apr; 126(1):1-8. PubMed ID: 20117135
[TBL] [Abstract][Full Text] [Related]
14. C-kit-positive cells accumulate in remodeled vessels of idiopathic pulmonary arterial hypertension.
Montani D; Perros F; Gambaryan N; Girerd B; Dorfmuller P; Price LC; Huertas A; Hammad H; Lambrecht B; Simonneau G; Launay JM; Cohen-Kaminsky S; Humbert M
Am J Respir Crit Care Med; 2011 Jul; 184(1):116-23. PubMed ID: 21471108
[TBL] [Abstract][Full Text] [Related]
15. Bone morphogenetic protein receptor-2 signaling promotes pulmonary arterial endothelial cell survival: implications for loss-of-function mutations in the pathogenesis of pulmonary hypertension.
Teichert-Kuliszewska K; Kutryk MJ; Kuliszewski MA; Karoubi G; Courtman DW; Zucco L; Granton J; Stewart DJ
Circ Res; 2006 Feb; 98(2):209-17. PubMed ID: 16357305
[TBL] [Abstract][Full Text] [Related]
16. Endothelial cell dysfunction and cross talk between endothelium and smooth muscle cells in pulmonary arterial hypertension.
Humbert M; Montani D; Perros F; Dorfmüller P; Adnot S; Eddahibi S
Vascul Pharmacol; 2008; 49(4-6):113-8. PubMed ID: 18606248
[TBL] [Abstract][Full Text] [Related]
17. Endothelial progenitor cell therapy for the treatment of coronary disease, acute MI, and pulmonary arterial hypertension: current perspectives.
Ward MR; Stewart DJ; Kutryk MJ
Catheter Cardiovasc Interv; 2007 Dec; 70(7):983-98. PubMed ID: 18044749
[TBL] [Abstract][Full Text] [Related]
18. [The etiopathogenesis of pulmonary hypertension: inflammation, vascular remodeling].
Kayikçioğlu M
Anadolu Kardiyol Derg; 2010 Aug; 10 Suppl 1():5-8. PubMed ID: 20819761
[TBL] [Abstract][Full Text] [Related]
19. Sustained endothelial progenitor cell dysfunction after chronic hypoxia-induced pulmonary hypertension.
Marsboom G; Pokreisz P; Gheysens O; Vermeersch P; Gillijns H; Pellens M; Liu X; Collen D; Janssens S
Stem Cells; 2008 Apr; 26(4):1017-26. PubMed ID: 18258720
[TBL] [Abstract][Full Text] [Related]
20. Endothelial progenitor cell-based therapy for pulmonary arterial hypertension.
Yang JX; Pan YY; Zhao YY; Wang XX
Cell Transplant; 2013; 22(8):1325-36. PubMed ID: 23295102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
